Tag: domagrozumab

Pfizer DMD drug domagrozumab fails in two clinical trials

pharmanewsdaily- August 31, 2018

Pfizer DMD drug update : US pharma giant Pfizer will scrap a couple of ongoing clinical trials evaluating its humanized monoclonal antibody domagrozumab (PF-06252616) for ... Read More